|
"yen fs"的相关文件
显示项目 51-90 / 90 (共2页)
<< < 1 2
每页显示[10|25|50]项目
| 國家衛生研究院 |
2021-09-16 |
Epidemiological characteristics of diabetic kidney disease in Taiwan
|
Wang, JS;Yen, FS;Lin, KD;Shin, SJ;Hsu, YH;Hsu, CC |
| 國家衛生研究院 |
2021-07-01 |
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Huang, YH;Hou, MC;Hwu, CM;Lo, YR;Shin, SJ;Hsu, CC |
| 國家衛生研究院 |
2021-07 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS;Wei, CC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-06-12 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS;Lai, JN;Wei, JCC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2021-04-29 |
Urate-lowering therapy and chronic kidney disease development in patients with gout
|
Yen, FS;Wei, JCC;Chang, CL;Yang, CC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-03-05 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
|
Yen, FS;Hsu, CC;Su, YC;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2021-02-18 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS;Wei, JC;Lin, MC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2021 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS; Wei, JCC; Lin, MC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy A nationwide retrospective cohort study
|
Yen, FS; Hsu, CC; Su, YC; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2021 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hsu, CC; Hou, MC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
|
Yen, FS; Wei, JCC; Chang, CL; Yang, CC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering therapy exerts protective effects against hypertension development in patients with gout
|
Lin, KH; Yen, FS; Li, HL; Wei, JCC; Hsu, CC; Yang, CC; Hwu, CM |
| 國家衛生研究院 |
2020-12-14 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS;Lai, JN;Wei, JC;Chiu, LT;Hwu, CM;Hou, MC;Hsu, CC |
| 國家衛生研究院 |
2020-10-30 |
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Wei, JC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2020-09 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS;Wei, JCC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2020-06-24 |
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JC;Yang, YC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2020-06-23 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS;Hsu, CC;Li, HL;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2020-06-22 |
Persons with type 2 diabetes and high insulin persistence were associated with lower risk of mortality: A nationwide retrospective cohort study
|
Yen, FS;Wei, JC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2020-05-04 |
Urate-lowering therapy exerts protective effects against hypertension development in patients with gout
|
Lin, KH;Yen, FS;Li, HL;Wei, JCC;Hsu, CC;Yang, CC;Hwu, CM |
| 國家衛生研究院 |
2020-02-27 |
Urate-lowering therapy may prevent the development of coronary artery disease in patients with gout
|
Yen, FS;Hsu, CC;Li, HL;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2020-01-21 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS;Yang, YC;Hwu, CM;Wei, JC;Huang, YH;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2020 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2020 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS; Yang, YC; Hwu, CM; Wei, JCC; Huang, YH; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus
|
Yen, FS; Wang, HC; Pan, CW; Wei, JCC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 國家衛生研究院 |
2019-09-23 |
Pioglitazone exposure reduced the risk of all-cause mortality in insulin-treated patients with type 2 diabetes mellitus
|
Yen, FS;Wang, HC;Pan, CW;Wei, JC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2019-01 |
All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
|
Yen, FS;Chiang, JH;Hwu, CM;Yen, YH;Lin, BJ;Wei, JCC;Hsu, CC |
| 國家衛生研究院 |
2018-10-04 |
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matchedsubject design
|
Yen, FS;Chen, W;Wei, JCC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2018-08-02 |
Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin
|
Hsu, PF;Sung, SH;Cheng, HM;Shin, SJ;Lin, KD;Chong, K;Yen, FS;Yu, BH;Huang, CT;Hsu, CC |
| 國家衛生研究院 |
2018-04-12 |
Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy
|
Yen, FS;Chiang, JH;Pan, CW;Lin, BJ;Wei, JC;Hsu, CC |
| 國家衛生研究院 |
2017-10 |
A point-based mortality prediction system for older adults with diabetes
|
Chang, YK;Huang, LF;Shin, SJ;Lin, KD;Chong, K;Yen, FS;Chang, HY;Chuang, SY;Hsieh, TJ;Hsiung, CA;Hsu, CC |
| 臺北醫學大學 |
1997 |
A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.
|
李俊年; Hwang SJ; Wu JC; Lee CN; Yen FS; Lu CL; Lin TP and Lee SD |
显示项目 51-90 / 90 (共2页)
<< < 1 2
每页显示[10|25|50]项目
|
